Drug
Aceneuramic Acid
Aceneuramic Acid: highest development phase Phase 3, developed by Ultragenyx Pharmaceutical. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Ultragenyx Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| Aceneuramic Acid Extended-Release Tablets NCT02736188 | Phase 3 | Hereditary Inclusion Body Myopathy |
| Aceneuramic Acid Extended-Release NCT02731690 | Phase 2 | Hereditary Inclusion Body Myopathy |
Latest
No recent events.
Follow Aceneuramic Acid on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.